<rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:digibug.ugr.es:10481/106150">
      <dc:title>Sexual Dysfunction in Melanoma Survivors: A Cross-Sectional Study on Prevalence and Associated Factors</dc:title>
      <dc:creator>Muñoz Barba, Daniel</dc:creator>
      <dc:creator>Sánchez Díaz, Manuel</dc:creator>
      <dc:creator>Molina Leyva, Alejandro</dc:creator>
      <dc:creator>Martínez López, Antonio</dc:creator>
      <dc:creator>Arias Santiago, Salvador</dc:creator>
      <dc:subject>Melanoma</dc:subject>
      <dc:subject>Quality of life</dc:subject>
      <dc:subject>Sexual dysfunction</dc:subject>
      <dc:description>Background/Objectives: Melanoma is a skin cancer that can lead to a poor prognosis.&#xd;
Unlike other oncologic diseases, there is scarce evidence regarding sexual function in&#xd;
melanoma patients, as well as factors associated with sexual dysfunction (SD). The aim&#xd;
of this study was to evaluate SD in a cohort of melanoma patients, as well as to describe&#xd;
associated factors. Methods: A cross-sectional analysis was conducted in individuals&#xd;
diagnosed with melanoma. Data regarding sociodemographic characteristics, clinical stage&#xd;
of the disease, quality of life, and sexual functioning were obtained through the use of&#xd;
validated assessment tools. The duration of the study was from 1 January 2023 to 1 January&#xd;
2024. Results: Seventy-five patients were included. The mean age was 52.70 ± 14.07 years,&#xd;
and 61.33% (46/75) were females. Melanomas at stages III or IV comprised 18.67% (14/75)&#xd;
of the sample. A negative impact of the melanoma on sexual function was reported by&#xd;
29.33% (22/75) of patients, with low sexual desire being the most frequent cause. Female&#xd;
SD was associated with older age, shorter disease duration, greater depression rates, and&#xd;
visible scar location after melanoma surgery (p &lt; 0.05). Male SD correlated with higher&#xd;
anxiety and depression rates and worse quality of life (p &lt; 0.05). No association was found&#xd;
for melanoma stage in any case (p > 0.30). Conclusions: Melanoma patients may suffer&#xd;
from SD, which can be associated with mood status disturbances, poor quality of life, and&#xd;
older age. Since the most frequent causes of a negative impact on sexuality are a reduction&#xd;
in sexual desire and the side effects of melanoma surgery, patients should be specifically&#xd;
asked about sexuality to improve holistic care of the disease, irrespective of disease stage.</dc:description>
      <dc:date>2025-09-08T11:05:35Z</dc:date>
      <dc:date>2025-09-08T11:05:35Z</dc:date>
      <dc:date>2025-07-10</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>Muñoz-Barba, D.; Sánchez-Díaz, M.; Molina-Leyva, A.; Martínez-López, A.; Arias-Santiago, S. Sexual Dysfunction in Melanoma Survivors: A Cross-Sectional Study on Prevalence and Associated Factors. J. Clin. Med. 2025, 14, 4891. https://doi.org/10.3390/jcm14144891</dc:identifier>
      <dc:identifier>https://hdl.handle.net/10481/106150</dc:identifier>
      <dc:identifier>10.3390/jcm14144891</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Atribución 4.0 Internacional</dc:rights>
      <dc:publisher>MDPI</dc:publisher>
   </ow:Publication>
</rdf:RDF>